Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Financial statements
| Fiscal year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|
| Research and development | $13.1K12 | |||||||
| Selling, general and admin | $24.0K5 | $23.7K5 | ||||||
| Operating expenses | $163.3K2 | |||||||
| Operating income | -$2.3M4 | $1.1M5 | -$45.0K6 | -$27.8K7 | -$5.7K8 | -$5.5K9 | -$68.7K2 | -$163.3K2 |
| Interest | $2.2K4 | $04 | $1.2K6 | $5.6K7 | $8.3K8 | $9.5K9 | $10.4K2 | $32.1K2 |
| Income tax | $04 | $04 | ||||||
| Net income | -$2.3M4 | $1.2M5 | -$51.2K6 | -$28.4K7 | -$14.0K8 | -$15.0K9 | -$76.1K2 | -$165.0K2 |
| Fiscal year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|
| Cash | $05 | $06 | $07 | $08 | ||||
| Current assets | $259.3K4 | $1.3K5 | $3.0K6 | $2.3K7 | $5278 | $4088 | ||
| Total assets | $281.4K4 | $1.3K5 | $3.0K6 | $2.3K7 | $5278 | $4089 | $261.2K2 | $130.3K2 |
| Accounts payable | $224.5K2 | |||||||
| Current liabilities | $288.6K4 | $142.8K5 | $195.7K6 | $223.4K7 | $235.6K8 | $250.5K8 | ||
| Total liabilities | $288.6K4 | $142.8K5 | $195.7K6 | $223.4K7 | $235.6K8 | $250.5K9 | $587.3K2 | $621.5K2 |
| Retained earnings | -$5.4M2 | |||||||
| Shareholders’ equity | -$7.3K5 | -$141.5K6 | -$192.7K7 | -$221.1K8 | -$235.1K9 | -$250.1K2 | -$326.2K2 | -$491.2K2 |
| Shares outstanding | 78.4M shares4 | 78.4M shares5 | 78.4M shares6 | 78.4M shares7 | 78.4M shares8 | 78.4M shares9 | 78.4M shares2 | 78.4M shares2 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Compare Retrieve Medical Holdings, Inc. with another company
Leadership
Who has led Retrieve Medical Holdings, Inc., and when. Pick a name to see everywhere that person has worked.
Chief executive
Chair
President
Chief financial officer
- Chief executive officerNadine C. Smith Oct 28, 2013 to Oct 28, 201313
- ChairNadine C. Smith Oct 28, 2013 to Oct 28, 201313
- PresidentNadine C. Smith Oct 28, 2013 to Oct 28, 201313
- PresidentFadi Zeidan Dec 21, 2009 to Dec 21, 200914
- Chief financial officerArnold Tinter Dec 20, 2013 to Dec 20, 201315
Board members and other officers (3)
- Board memberStuart A. Sundlun Dec 20, 2013 to Dec 20, 201316
- Board memberFadi Zeidan Dec 21, 2009 to Dec 21, 200914
- Board memberUfuk Turk Dec 21, 2009 to Dec 21, 200917
Named in SEC Form D filings
People the company listed in its private-offering notices.
- Executive OfficerJerry Swon named Aug 14, 2023 to Oct 28, 202418
- Executive OfficerJoerg Klaube named Aug 14, 2023 to Oct 28, 202418
- DirectorJason C Pottinger named Aug 14, 2023 to Oct 28, 202418
- DirectorLouis C Rose named Aug 14, 2023 to Oct 28, 202418
- DirectorMark Rosenberg named Aug 14, 2023 to Oct 28, 202418
- DirectorTodd C Griffith named Aug 14, 2023 to Oct 28, 202418
Former names
Timeline
Filings
25 filings to the SEC since October 2021: 5 annual reports, 13 quarterly reports, 1 major events, 2 private raises, 4 other. The latest 20:
- Oct 28, 2024D EDGAR
- Sep 17, 2024C-U EDGAR
- May 10, 2024C/A EDGAR
- Mar 14, 2024C EDGAR
- Aug 14, 2023D EDGAR
- Mar 21, 202315-12G PEAK PHARMACEUTICALS, INC. FORM 15-12G EDGAR
- Feb 9, 202310-Q PEAK PHARMACEUTICALS 12/31/22 FORM 10-Q EDGAR
- Jan 20, 20238-K PEAK PHARMACEUTICALS, INC. 8-K EDGAR
- Dec 19, 202210-K PEAK PHARMACEUTICALS, INC. 09/30/2022 10-K EDGAR
- Dec 19, 202210-Q PEAK PHARMACEUTICALS, INC. 06/30/2022 10-Q EDGAR
- Dec 19, 202210-Q PEAK PHARMACEUTICALS, INC. 03/31/2022 10-Q EDGAR
- Dec 19, 202210-Q PEAK PHARMACEUTICALS, INC. 12/31/2021 10-Q EDGAR
- Dec 19, 202210-K PEAK PHARMACEUTICALS, INC. 09/30/2021 10-K EDGAR
- Dec 19, 202210-Q PEAK PHARMACEUTICALS, INC. 06/30/2021 10-Q EDGAR
- Dec 19, 202210-Q PEAK PHARMACEUTICALS, INC. 03/31/2021 10-Q EDGAR
- Dec 19, 202210-Q PEAK PHARMACEUTICALS, INC. 12/31/2020 10-Q EDGAR
- Dec 19, 202210-K PEAK PHARMACEUTICALS, INC. 09/30/2020 10-K EDGAR
- Dec 19, 202210-Q PEAK PHARMACEUTICALS, INC. 06/30/2020 10-Q EDGAR
- Dec 19, 202210-Q PEAK PHARMACEUTICALS, INC. 03/31/2020 10-Q EDGAR
- Dec 19, 202210-Q PEAK PHARMACEUTICALS, INC. 12/31/2019 10-K EDGAR
The 25 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Money raised
Private offerings the company reported to the SEC on Form D.
SEC filer profile
How Retrieve Medical Holdings, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARRetrieve Medical Holdings, Inc.1
- CIK0001452804
- Filer statusNon-accelerated filer<br>smaller reporting company1
- Incorporated inNevada1
- Fiscal year endsSeptember 301
- Industry code (SIC)2834 Pharmaceutical Preparations1
- SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
- Business address376 Main Street, Suite 100, Bedminster, NJ 079211
- Phone908-800-28801
- Shares outstanding78,363,567 as of Feb 8, 202311
- Public float$5.1M as of Mar 31, 20222
- On EDGAR sinceDec 29, 20081
- Filings120 in all: 10-Q (43), 8-K (24), 10-K (14), 3 (6), NT 10-K (4), NT 10-Q (4), UPLOAD (4), D (3)1
All 24 form types
10-K/A (2), S-1/A (2), 10-Q/A (1), 15-12G (1), 15-15D (1), 424B3 (1), 8-A12G (1), C (1), C-U (1), C/A (1), CORRESP (1), DEF 14C (1), EFFECT (1), PRE 14C (1), S-1 (1), SC 13D (1)
- Latest filingsAnnual report (10-K) Dec 19, 2022
Quarterly report (10-Q) Feb 9, 2023
Latest 8-K (8-K) Jan 20, 2023
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14SEC EDGARFadi Zeidan, President
- 15
- 16SEC EDGARStuart A. Sundlun, Board member
- 17SEC EDGARUfuk Turk, Board member
- 18
- 19SEC EDGARChange of auditor